FDA Approved: CRENESSITY — Original Application (Neurocrine Biosciences, Inc.)

View source ↗

Summary

FDA approved CRENESSITY (crinecerfont) from Neurocrine Biosciences, granting its first approval for congenital adrenal hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• CRENESSITY (crinecerfont)

Snippet

ORIG AP for CRENESSITY (CRINECERFONT)